Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / HOTH - Hoth inks research agreement for development of mRNA cancer therapy

HOTH - Hoth inks research agreement for development of mRNA cancer therapy

Hoth Therapeutics Inc.
Hoth Therapeutics (NASDAQ:HOTH) has signed a sponsored research agreement with North Carolina State University for the development of HT-KIT, an mRNA therapeutic for mast cell cancers. The research will center on characterizing the HT-KIT dose and  frequency for treatment of aggressive mastocytosis and mast cell neoplasms using humanized tumor mouse models. In addition, the research will examine the use of HT-KIT for other potential cancers, such as as gastrointestinal stromal tumors and acute myeloid leukemia. Read about phase 1 results for the company's BioLexa platform to treat atopic dermatitis.

For further details see:

Hoth inks research agreement for development of mRNA cancer therapy
Stock Information
Company Name: Hoth Therapeutics Inc.
Stock Symbol: HOTH
Market: NASDAQ
Website: hoththerapeutics.com
Menu
HOTH HOTH Quote HOTH Short HOTH News HOTH Articles HOTH Message Board
Get HOTH Alerts

News, Short Squeeze, Breakout and More Instantly...